DLA
ABT icon

Douglas Lane & Associates’s Abbott ABT Stock Holding History

Douglas Lane & Associates’s Portfolio ABT Stock Details ABT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.27M Sell
13,999
-42
-0.3% -$3.83K 0.02% 157
2026
Q1 		$1.44M Sell
14,041
-115
-0.8% -$13K 0.02% 148
2025
Q4 		$1.77M Sell
14,156
-746
-5% -$95K 0.02% 143
2025
Q3 		$2M Sell
14,902
-441
-3% -$57.9K 0.03% 144
2025
Q2 		$2.09M Buy
15,343
+34
+0.2% +$4.48K 0.03% 141
2025
Q1 		$2.03M Sell
15,309
-157
-1% -$20K 0.03% 143
2024
Q4 		$1.75M Sell
15,466
-158
-1% -$18.3K 0.02% 148
2024
Q3 		$1.78M Sell
15,624
-503
-3% -$55.2K 0.02% 147
2024
Q2 		$1.68M Buy
16,127
+423
+3% +$44.8K 0.02% 147
2024
Q1 		$1.78M Sell
15,704
-417
-3% -$47.8K 0.03% 147
2023
Q4 		$1.77M Sell
16,121
-688
-4% -$68.7K 0.03% 143
2023
Q3 		$1.63M Buy
16,809
+725
+5% +$76.1K 0.03% 138
2023
Q2 		$1.75M Buy
16,084
+101
+0.6% +$10.8K 0.03% 135
2023
Q1 		$1.62M Buy
15,983
+302
+2% +$31.9K 0.03% 141
2022
Q4 		$1.72M Sell
15,681
-210
-1% -$21.7K 0.03% 139
2022
Q3 		$1.54M Buy
15,891
+296
+2% +$31.5K 0.03% 137
2022
Q2 		$1.69M Sell
15,595
-736
-5% -$83.6K 0.03% 137
2022
Q1 		$1.93M Sell
16,331
-1,228
-7% -$152K 0.03% 139
2021
Q4 		$2.47M Buy
17,559
+1,126
+7% +$144K 0.03% 138
2021
Q3 		$1.94M Sell
16,433
-820
-5% -$101K 0.03% 140
2021
Q2 		$2M Buy
17,253
+994
+6% +$116K 0.03% 136
2021
Q1 		$1.95M Buy
16,259
+776
+5% +$91.9K 0.03% 131
2020
Q4 		$1.7M Sell
15,483
-346
-2% -$37.6K 0.03% 131
2020
Q3 		$1.72M Sell
15,829
-1,119
-7% -$114K 0.03% 129
2020
Q2 		$1.55M Sell
16,948
-104
-0.6% -$9.4K 0.03% 127
2020
Q1 		$1.35M Sell
17,052
-237
-1% -$19.8K 0.04% 131
2019
Q4 		$1.5M Sell
17,289
-518
-3% -$43.4K 0.03% 136
2019
Q3 		$1.49M Sell
17,807
-6,669
-27% -$567K 0.03% 135
2019
Q2 		$2.06M Buy
24,476
+415
+2% +$32.7K 0.04% 131
2019
Q1 		$1.92M Sell
24,061
-132
-0.5% -$9.82K 0.04% 132
2018
Q4 		$1.75M Sell
24,193
-2,267
-9% -$159K 0.04% 127
2018
Q3 		$1.94M Sell
26,460
-177
-0.7% -$11.6K 0.04% 131
2018
Q2 		$1.63M Sell
26,637
-1,924
-7% -$117K 0.03% 130
2018
Q1 		$1.71M Sell
28,561
-1,240
-4% -$74.7K 0.04% 128
2017
Q4 		$1.7M Buy
29,801
+928
+3% +$51.4K 0.04% 128
2017
Q3 		$1.54M Sell
28,873
-4,924
-15% -$247K 0.04% 131
2017
Q2 		$1.64M Sell
33,797
-5,654
-14% -$256K 0.04% 133
2017
Q1 		$1.75M Sell
39,451
-6,354
-14% -$275K 0.04% 135
2016
Q4 		$1.76M Sell
45,805
-7,716
-14% -$306K 0.04% 137
2016
Q3 		$2.26M Sell
53,521
-27,321
-34% -$1.17M 0.06% 136
2016
Q2 		$3.18M Sell
80,842
-20,307
-20% -$808K 0.09% 130
2016
Q1 		$4.23M Buy
+101,149
New +$4.01M 0.12% 125

Other funds holding ABT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Douglas Lane & Associates's ABT Position: Q2 2026 in Review

Douglas Lane & Associates reduced its Abbott (ABT) stake by 0.3% in Q2 2026, selling an estimated $3.83K and leaving 13,999 shares worth $1.27M. The position accounts for 0.02% of the portfolio, ranked #157.

Douglas Lane & Associates first reported a position in ABT in Q1 2016 and has held it in 42 quarters since. The position peaked at $4.23M in Q1 2016. 2,956 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Douglas Lane & Associates held 13,999 shares of Abbott worth $1.27M as of Q2 2026.
  • Douglas Lane & Associates sold 42 Abbott shares in Q2 2026, an estimated $3.83K.
  • Abbott made up 0.02% of Douglas Lane & Associates's portfolio in Q2 2026, its #157 holding.
  • Douglas Lane & Associates first reported a position in Abbott in Q1 2016 and has held it in 42 quarters since.
  • Douglas Lane & Associates's Abbott position peaked at $4.23M in Q1 2016.
  • 2,956 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Douglas Lane & Associates's 13F filing for Q2 2026, filed 14 Jul 2026.